[EFFECT] Oncotelic Therapeutics, Inc. SEC Filing

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

EFFECT

Rhea-AI Filing Summary

Analyzing...

12/29/2025 - 12:15 AM

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	December 23, 2025 4:00 P.M.

Form:

S-1

CIK:	0000908259
Company Name:	Oncotelic Therapeutics, Inc.
File Number:	333-291724

Source: View Original Filing on SEC EDGAR

Oncotelic Therapeutics Inc

OTC:OTLC

OTLC Rankings

N/A Ranked by Market Cap

N/A Ranked by Dividends

OTLC Latest News

Feb 20, 2026

Oncotelic Therapeutics Inc. (OTCQB: OTLC) Announces Expanded IP Coverage, Strengthening Position in Biotech Evolution

Feb 18, 2026

Oncotelic Therapeutics Inc. (OTCQB: OTLC) Key IP Portfolio Advancements Align with Biotech Asset Trend

Feb 12, 2026

Oncotelic Therapeutics, Inc. and Sapu Bioscience Expand International IP Coverage for OT-101, Strengthening CNS and Neurology Commercialization Pathway

Feb 10, 2026

Oncotelic Therapeutics, Inc. Showcases Multi-Year Execution and Validation, Enters 2026 with Late-Stage Momentum Across Diversified Pipeline

Dec 22, 2025

Oncotelic Therapeutics Details PDAOAI Platform and Opens Access to Its Total TGF-β Knowledge Corpus

OTLC Latest SEC Filings

Jan 29, 2026

[8-K] Oncotelic Therapeutics, Inc. Reports Material Event

Jan 26, 2026

[Form 4] Oncotelic Therapeutics, Inc. Insider Trading Activity

Jan 26, 2026

[8-K] Oncotelic Therapeutics, Inc. Reports Material Event

Jan 7, 2026

[8-K] Oncotelic Therapeutics, Inc. Reports Material Event

Jan 6, 2026

[8-K] Oncotelic Therapeutics, Inc. Reports Material Event

OTLC Stock Data

Market Cap 21.75M

Float 226.00M

Industry Biotechnology

Sector Healthcare

Website Link

Country United States

City Agoura Hills